73

Oncology
Prevention and treatment of tumors, and caring for cancer patients.
Sub Categories on Oncology
Latest Articles
AI can predict the effectiveness of breast cancer chemotherapy

AI can predict the effectiveness of breast cancer chemotherapy

byUniversity of WaterlooCredit: Unsplash/CC0 Public DomainEngineers at the University of Waterloo have developed artificial intelligence (AI) technology to predict if women with breast cancer wo

AI can predict the effectiveness of breast cancer chemotherapy

byUniversity of WaterlooCredit: Unsplash/CC0 Public DomainEngineers at the University of Waterloo have developed artificial intelligence (AI) technology to predict if women with breast cancer wo
Adcetris FDA approval expanded to include later-stage Hodgkin's

Adcetris FDA approval expanded to include later-stage Hodgkin's

(HealthDay)—U.S. Food and Drug Administration approval of Adcetris (brentuximab vedotin) has been expanded to include adults with untreated stage III or IV classical Hodgkin's lymphoma, the agency

Adcetris FDA approval expanded to include later-stage Hodgkin's

(HealthDay)—U.S. Food and Drug Administration approval of Adcetris (brentuximab vedotin) has been expanded to include adults with untreated stage III or IV classical Hodgkin's lymphoma, the agency
Plasma growth hormone is a potential biomarker of response to atezolizumab and bevacizumab in advanced HCC patients

Plasma growth hormone is a potential biomarker of response to atezolizumab and bevacizumab in advanced HCC patients

by Impact Journals LLCOverall survival- log rank test was used; fifteen of the 19 GH-high patients died, the median OS was 9.26 months (95% CI: 7.59, 14.59). Credit: 2022 Mohamed et al.A new research

Plasma growth hormone is a potential biomarker of response to atezolizumab and bevacizumab in advanced HCC patients

by Impact Journals LLCOverall survival- log rank test was used; fifteen of the 19 GH-high patients died, the median OS was 9.26 months (95% CI: 7.59, 14.59). Credit: 2022 Mohamed et al.A new research
Active surveillance OK for non-muscle invasive bladder cancer

Active surveillance OK for non-muscle invasive bladder cancer

(HealthDay)—For patients with non-muscle invasive bladder cancer, active surveillance seems reasonable and cost-effective, according to a study published in the February issue ofThe Journal of U

Active surveillance OK for non-muscle invasive bladder cancer

(HealthDay)—For patients with non-muscle invasive bladder cancer, active surveillance seems reasonable and cost-effective, according to a study published in the February issue ofThe Journal of U
Scientists develop a new model for glioblastoma using gene-edited organoids

Scientists develop a new model for glioblastoma using gene-edited organoids

by Salk InstituteOrganoids reveal how a deadly brain cancer grows. From left to right, tumor cells labeled with red fluorescent marker tdTomato spread in a cerebral organoid over a time period of

Scientists develop a new model for glioblastoma using gene-edited organoids

by Salk InstituteOrganoids reveal how a deadly brain cancer grows. From left to right, tumor cells labeled with red fluorescent marker tdTomato spread in a cerebral organoid over a time period of
Long-term cardiomyopathy risk varies by chemo agent

Long-term cardiomyopathy risk varies by chemo agent

(HealthDay)—Long-term cardiomyopathy risk varies by chemotherapy agent for childhood cancer survivors, with a decreased risk for daunorubicin versus doxorubicin, according to a study recently publishe

Long-term cardiomyopathy risk varies by chemo agent

(HealthDay)—Long-term cardiomyopathy risk varies by chemotherapy agent for childhood cancer survivors, with a decreased risk for daunorubicin versus doxorubicin, according to a study recently publishe
Novel genomics tool enables more accurate identification of rare mutations in cancer cells

Novel genomics tool enables more accurate identification of rare mutations in cancer cells

by New York Genome CenterExample of colored de Bruijn graph rendered to represent genomic data for a short region of 400 base pairs using the Lancet genomics tool developed by New York Genome Center s

Novel genomics tool enables more accurate identification of rare mutations in cancer cells

by New York Genome CenterExample of colored de Bruijn graph rendered to represent genomic data for a short region of 400 base pairs using the Lancet genomics tool developed by New York Genome Center s
Medicaid expansion in Southern states associated with earlier and more comprehensive breast cancer treatment

Medicaid expansion in Southern states associated with earlier and more comprehensive breast cancer treatment

byAmerican College of SurgeonsCredit: Unsplash/CC0 Public DomainPatients diagnosed with invasive breast cancer in a Southern state that expanded access to Medicaid were more likely to receive tr

Medicaid expansion in Southern states associated with earlier and more comprehensive breast cancer treatment

byAmerican College of SurgeonsCredit: Unsplash/CC0 Public DomainPatients diagnosed with invasive breast cancer in a Southern state that expanded access to Medicaid were more likely to receive tr
Researcher: Big data, networks identify cell signaling pathways in lung cancer

Researcher: Big data, networks identify cell signaling pathways in lung cancer

by University of MontanaThe cover of the May 22 issue ofScience Signalingfeatures a three-dimensional representation of lung cancer protein modifications produced by the machine learn

Researcher: Big data, networks identify cell signaling pathways in lung cancer

by University of MontanaThe cover of the May 22 issue ofScience Signalingfeatures a three-dimensional representation of lung cancer protein modifications produced by the machine learn
Researchers are building detailed maps of colorectal cancer to better understand the dynamics of the disease

Researchers are building detailed maps of colorectal cancer to better understand the dynamics of the disease

by Harvard Medical SchoolA 3D reconstruction of colorectal cancer revealed that what was once thought to be 2D mucin pools with clusters of cancer cells floating inside is actually a complex and

Researchers are building detailed maps of colorectal cancer to better understand the dynamics of the disease

by Harvard Medical SchoolA 3D reconstruction of colorectal cancer revealed that what was once thought to be 2D mucin pools with clusters of cancer cells floating inside is actually a complex and
New review on p53 biology and reactivation in blood cancers

New review on p53 biology and reactivation in blood cancers

byKarolinska InstitutetA simplified scheme of p53 regulation in cells upon stress and the drugs currently evaluated in clinical trials for p53 reactivation for improved therapy in MDS and AML. C

New review on p53 biology and reactivation in blood cancers

byKarolinska InstitutetA simplified scheme of p53 regulation in cells upon stress and the drugs currently evaluated in clinical trials for p53 reactivation for improved therapy in MDS and AML. C
Two studies describe improved approach to bone marrow transplant

Two studies describe improved approach to bone marrow transplant

by Cincinnati Children's Hospital Medical CenterThese images from scientists at Cincinnati Children's show hematopoietic stem cells (blood stem cells) from donor laboratory mice. The dono

Two studies describe improved approach to bone marrow transplant

by Cincinnati Children's Hospital Medical CenterThese images from scientists at Cincinnati Children's show hematopoietic stem cells (blood stem cells) from donor laboratory mice. The dono